- Home
- IOBT vs ENZ Comparison
IOBT vs ENZ Comparison
Compare IOBT & ENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOBT
- ENZ
- Stock Information
- Founded
- IOBT 2014
- ENZ 1976
- Country
- IOBT Denmark
- ENZ United States
- Employees
- IOBT N/A
- ENZ N/A
- Industry
- IOBT Biotechnology: Pharmaceutical Preparations
- ENZ Medical Specialities
- Sector
- IOBT Health Care
- ENZ Health Care
- Exchange
- IOBT Nasdaq
- ENZ Nasdaq
- Market Cap
- IOBT 56.7M
- ENZ 37.9M
- IPO Year
- IOBT 2021
- ENZ N/A
- Fundamental
- Price
- IOBT $0.77
- ENZ $0.71
- Analyst Decision
- IOBT Strong Buy
- ENZ
- Analyst Count
- IOBT 3
- ENZ 0
- Target Price
- IOBT $9.33
- ENZ N/A
- AVG Volume (30 Days)
- IOBT 629.4K
- ENZ 213.3K
- Earning Date
- IOBT 11-12-2024
- ENZ 12-16-2024
- Dividend Yield
- IOBT N/A
- ENZ 14.18%
- EPS Growth
- IOBT N/A
- ENZ N/A
- EPS
- IOBT N/A
- ENZ N/A
- Revenue
- IOBT N/A
- ENZ $30,314,000.00
- Revenue This Year
- IOBT N/A
- ENZ N/A
- Revenue Next Year
- IOBT N/A
- ENZ N/A
- P/E Ratio
- IOBT N/A
- ENZ N/A
- Revenue Growth
- IOBT N/A
- ENZ N/A
- 52 Week Low
- IOBT $0.66
- ENZ $0.68
- 52 Week High
- IOBT $2.10
- ENZ $1.50
- Technical
- Relative Strength Index (RSI)
- IOBT 38.48
- ENZ 15.75
- Support Level
- IOBT $0.75
- ENZ $0.68
- Resistance Level
- IOBT $0.84
- ENZ $1.05
- Average True Range (ATR)
- IOBT 0.07
- ENZ 0.06
- MACD
- IOBT 0.00
- ENZ -0.03
- Stochastic Oscillator
- IOBT 16.90
- ENZ 5.56
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.
About ENZ Enzo Biochem Inc. ($0.01 Par Value)
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. The company has one reportable segment, Products, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins.